EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Recent progress in vaccine development targeting pre-clinical human toxoplasmosis

Ki-Back Chu, Fu-Shi Quan

Parasites, Hosts and Diseases · 2023

DOI: 10.3347/phd.22097 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Parasites, Hosts and Diseases, 2023. Verfasst von Ki-Back Chu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Center for Bioreaction to Reactive Oxygen Species and Biomedical Science Institute, Core Research Institute, School of Medicine, Kyu…. Hauptthemen laut MEDLINE: Toxoplasma, Toxoplasmosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Toxoplasma gondii is an intracellular parasitic organism affecting all warm-blooded vertebrates. Due to the unavailability of commercialized human T. gondii vaccine, many studies have been reported investigating the protective efficacy of pre-clinical T. gondii vaccines expressing diverse antigens. Careful antigen selection and implementing multifarious immunization strategies could enhance protection against toxoplasmosis in animal models. Although none of the available vaccines could remove the tissue-dwelling parasites from the host organism, findings from these pre-clinical toxoplasmosis vaccine studies highlighted their developmental potential and provided insights into rational vaccine design. We herein explored the progress of T. gondii vaccine development using DNA, protein subunit, and virus-like particle vaccine platforms. Specifically, we summarized the findings from the pre-clinical toxoplasmosis vaccine studies involving T. gondii challenge infection in mice published in the past 5 years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ToxoplasmaToxoplasmosisHumansAnimalsMiceEthnicityImmunizationVaccine Development

Stichwörter der Autor:innen

DNAToxoplasma gondiiprotein subunitvaccinevirus-like particle

Autor:innen und Institutionen

  • Medical Research Center for Bioreaction to Reactive Oxygen Species and Biomedical Science Institute, Core Research Institute, School of Medicine, Kyung Hee University, Seoul 02447, Korea.
  • Department of Medical Zoology, School of Medicine, Kyung Hee University, Seoul 02447, Korea.

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Chu, K. B., & Quan, F. S. (2023). Recent progress in vaccine development targeting pre-clinical human toxoplasmosis. Parasites, Hosts and Diseases. https://doi.org/10.3347/phd.22097

Vancouver

Chu KB, Quan FS. Recent progress in vaccine development targeting pre-clinical human toxoplasmosis. Parasites, Hosts and Diseases. 2023. doi:10.3347/phd.22097

BibTeX
@article{Chu2023,
  author = {Chu, Ki-Back and Quan, Fu-Shi},
  title = {Recent progress in vaccine development targeting pre-clinical human toxoplasmosis},
  journal = {Parasites, Hosts and Diseases},
  year = {2023},
  doi = {10.3347/phd.22097}
}
Kostenlos starten →